The Next Five Years for the Cannabis Industry

You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news.

Subscribe to receive our free weekly newsletter in your inbox each Sunday morning.

Friends,

This week, we quietly celebrated the fifth anniversary of the launch of New Cannabis Ventures. We said at launch that we expected our platform would save investors, entrepreneurs, media and regulatory authorities time as they work to stay on top of the industry, and we believe we have stayed true to this mission thus far.

The Heart of NCV

Despite starting at a time when investors were enduring a brutal bear market and giving up hope, we were optimistic that we could provide unique value to our readers and that this was an industry with a bright future. In the beginning, our focus was almost entirely smartly curated content published around the web, providing a valuable time savings service to help our readers discover news quickly that would help them stay on top of the industry, and soon after we moved to provide more exclusive content. While we still publish the most important qualified company press releases and distribute them across our website and mobile app platform, our published content has evolved substantially since the early days.

In addition to a thought-provoking newsletter delivered every Sunday, we have created important institutional-level proprietary resources that industry readers rely on, such as:

New Cannabis Ventures continues to be the leading dedicated news source where content is driven from a sophisticated financial analysis and fundamental research perspective. Our headlines are succinct, and we strive for published exclusive content to be fact-driven and reliable.

The Next Five Years

We are excited to think about the next five years. For New Cannabis Ventures, our readers can expect us to remain true to our mission of saving them time, providing valuable information and resources, helping them learn about companies finding success in the industry and further evolving our content. One thing we want our readers to know is that we will not be diluting our focus with coverage of psychedelics. In fact, we are glad to see others head in that direction, following many of the failed opportunists that have plagued our industry for years.

As we assess the industry outlook, one thing seems certain: Expect the future to have lots of ups and downs. As we have detailed in the past, we believe a new bull market began in the depths of despair in March, and we are encouraged to see early signs that the promise for the industry has brightened. We don’t expect full legalization in the next few years in the U.S., but we believe that federal policies may be rationalized, especially if the Senate control flips. We remind readers, though, that the bull thesis is one of status quo, as continued advancement state-by-state without any sort of federal interference can be very positive by itself. Potential regulatory reforms at the federal level add to the underlying positive outlook.

Other Trends We Anticipate

There are many things we look forward to seeing play out. For one, we believe investors have given up on Canada prematurely and that market could very much surprise many who have written it off as the slow-motion roll out finally hits its stride. The same can be said for California. We also think that the global markets have been slow to develop, but the next five years should see substantial expansion around the world and expect our attention will reflect more coverage of these markets. We have discussed the risks and opportunities of an alternative way of producing cannabinoids, biosynthesis, but we think regulatory challenges will limit the growth (think about CBD and the FDA). Finally, we anticipate more strategic partnerships and investments in the coming years between cannabis companies and mainstream companies, including pharmaceutical, tobacco, alcohol and CPG companies.

We want to thank our readers, the many cannabis operators and investors working to make this a great industry and the companies that have directly supported NCV for helping to make our first five years so gratifying, and we look forward to being your trusted source of news and data for the next five.


Why Cannabis Investors Subscribe to 420Investor.com

Real-time, market moving news and analysis! Cut out the noise and get the facts straight from the longest running full-time cannabis analyst.

If you’ve ever wondered why we don’t share every little detail with our readers publicly or on social media, it’s because we provide a premium service for cannabis investors. At 420 investor, Alan Brochstein has helped investors navigation the cannabis stock market since 2013. This is the go-to place for investors to learn, explore and profit from publicly-traded cannabis stocks. The primary goal of 420 Investor is to provide professional, real-time, objective information about the top cannabis companies. Learn more about what you are missing.


New Cannabis Ventures publishes curated articles as well as exclusive news. Here is some of the most interesting business content from this week:


To get real-time updates download our free mobile app for Android or Apple devices, like our Facebook page, or follow Alan on Twitter. Share and discover industry news with like-minded people on the largest cannabis investor and entrepreneur group on LinkedIn.

Get ahead of the crowd! If you are a cannabis investor and find value in our Sunday newsletters, subscribe to 420 Investor, Alan’s comprehensive stock due diligence platform since 2013. Gain immediate access to real-time and in-depth information and market intelligence about the publicly traded cannabis sector, including daily videos, weekly chats, model portfolios, a community forum and much more.

Use the suite of professionally managed NCV Cannabis Stock Indices to monitor the performance of publicly-traded cannabis companies within the day or over longer time-frames. In addition to the comprehensive Global Cannabis Stock Index, we offer a family of indices to track Canadian licensed producers as well as the American Cannabis Operator Index.

View the Public Cannabis Company Revenue & Income Tracker, which ranks the top revenue producing cannabis stocks that generate industry sales of more than US$10M per quarter.

Stay on top of some of the most important communications from public companies by viewing upcoming cannabis investor earnings conference calls.

Discover upcoming new listings with the curated Cannabis Stock IPOs and New Issues Tracker.

Sincerely,

Alan & Joel

Exclusive article by Alan Brochstein, CFA
Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online communities 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

Get Our Sunday Newsletter